Ryan Abbott


Last Updated May 1, 2017

Most available at SSRN: Download

Major Legal Publications

Ryan Abbott,
The Reasonable Computer: Disrupting the Paradigm of Tort Liability
, Geo. Wash. L. Rev. Forthcoming.

Ryan Abbott and Bret Bogenschneider,
Should Robots Pay Taxes? Tax Policy in the Age of Automation
, Harv. L. & Pol'y Rev. Forthcoming.

Ryan Abbott,
The Sentinel Initiative as a Cultural Commons
, In Governing Medical Research Commons, Katherine Strandburg, et al. eds. Cambridge University Press. Forthcoming.

Ryan Abbott,
Hal the Inventor: Big Data and Its Use by Artificial Intelligence
, In Big Data is Not a Monolith, Editors Hamid Ekbia, Michael Mattioli, and Cassidy Sugimoto. MIT Press. Forthcoming.

Ryan Abbott,
I Think, Therefore I Invent: Creative Computers and the Future of Patent Law
, Boston College Law Review, Vol. 57, No. 4 (2016). Forthcoming.

Ryan Abbott and Ian Ayres,
Evidence and Extrapolation: Mechanisms for Regulating Off-Label Use of Drugs and Diagnostics
, 64 Duke L.J. 377 (2014).

Ryan Abbott
Documenting Traditional Medical Knowledge
, World Intellectual Property Organization, (2014).

Ryan Abbott,
Big Data and Pharmacovigilance: Using Healthcare Information Exchanges to Revolutionize Drug Safety
, 99 Iowa L. Rev. 225 (2013).

Ryan Abbott,
Treating the Health Care Crisis: Complementary and Alternative Medicine for PPACA
, 14 DePaul J. Health Care L. 35 (2012).

Peer-Reviewed Publications

Ryan Abbott and David Smith,
The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.
, J Psychoactive Drugs; 2015 Nov-Dec;47(5):368-71.

Ryan Abbott, Ian Ayres, Ed Hui and Ka-Kit Hui,
Effect of Perineal Self-Acupressure on Constipation: A Randomized Controlled Trial
, J Gen Intern Med. 2015 Apr;30(4):434-9.

Ibrahim Alabbadi, Ryan Abbott and Deema Jaber,
Jordanian Stakeholder Attitudes Toward Generic Substitution
, Journal of Generic Medicines, March-June 2014 vol. 11 no. 1-2 24-34.

Abbott, Ryan,
Post-Market Drug Regulation in the Age of Big Data: What Path to the Promised Land?
, FDLI's Food and Drug Policy Forum, 4 (10), 1-14.

Ryan Abbott and Ian Ayres,
Can Bayesian Extrapolation Improve FDA Regulation of Off-Label Uses of Drugs and Devices?
, FDLI's Food and Drug Policy Forum; 4(5), 1-12, 2014.

Ryan Abbott & Michael Cohen,
Medico-Legal Issues in Cardiology
, Cardiology in Review 2013; 21:222-228.

Ryan Abbott, et al.,
The price of medicines in Jordan: the cost of trade-based intellectual property
. Medicines Transparency Alliance, 9 Journal of Generic Medicines 75 (2012).

Ryan Abbott, et al.,
Medical Student Attitudes Toward Complementary, Alternative, and Integrative Medicine
, 2011 Evid Based Complement Alternat Med 1.

Ryan Abbott et al.,
A Randomized Controlled Trial of Tai Chi for Tension Headaches
, 4 Evid Based Complement Alternat Med 107 (2007).

Additional Book Chapters

Ryan Abbott, Helen Lavretsky, Donald Chang, and Harris Eyre.
The Roles of Tai Chi, Qi Gong, and Mind-Body Practices in the Treatment and Prevention of Psychiatric Disorders. In Complementary and Integrative Treatments in Psychiatric Practice (Patricia L. Gerbarg, Phillip R. Muskin, and Richard P. Brown, eds.).
(American Psychiatric Press). Forthcoming.

Ryan Abbott & Helen Lavretsky,
Tai Chi and Qigong for the Treatment and Prevention of Mental Disorders. In Psychiatric Clinics of North America - Integrative Psychiatry. Editors: Phillip R. Muskin, et al.
(Elsevier, 2013).

Michael Cohen, Suzanne Natbony and Ryan Abbott,
Complementary and alternative medicine in child and adolescent psychiatry: legal considerations. Child Adolesc Psychiatr Clin N Am. 2013 Jul;22(3):493-507.

Solicited Publications

Richard Epstein and Ryan Abbott,
FDA Involvement in Off-Label Use: Debate Between Richard Epstein and Ryan Abbott
, 44 Sw. L. Rev. 1 (2014).

Abbott, Ryan and Carl Stevens,
Redefining Medical Necessity: A Consumer-Driven Solution to the U.S. Health Care Crisis
, 47 Loy. L.A. L. Rev. 943 (2014).

Ryan Abbott,
Balancing Access and Innovation in India's Shifting IP Regime, Remarks
, 35 Whittier Law Review 341 (2014).


Ryan Abbott,
Book Review: FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies.
, Journal of Law and the Biosciences, 1–5 (2015).

Ryan Abbott and Ka-Kit Hui,
Perineal Self-Acupressure’s Mechanism of Action.
, J Gen Intern Med. 2015 Apr;30(4):399. [Letter to the Editor].

Ryan Abbott,
Overcoming Barriers to a Global Treaty on Medical Funding and R&D
, 7 Journal of the Brazilian Institute for Intellectual Property 70 (2012).

Frederick Abbott et al.,
Health Research for Action, Regional Assessment of Patent and Related Issues and Access to Medicines: Caricom Member States and the Dominican Republic (HERA)
, 1 Health Research for Action Final Report-Main Report 1 (2009).

Ryan Abbott & Wilbert Bannenberg,
Health Research for Action, Regional Assessment of Patent and Related Issues and Access to Medicines: Caricom Member States and the Dominican Republic
, 2 Health Research for Action Final Report-Main 1 (2009).

Ryan Abbott,
The Beijing Declaration-A Milestone for Traditional Medicine
, 13 ICTSD-Bridges 21 (2009).

Blog Posts

Bill of Health, A Blog by Harvard Law School Petrie-Flom Center & Friends: Website

- “Government Regulation of Commercial Speech: is Amarin Pharma’s Breakout Moment?” 7 Sep. 2015. View

- “The People of the State of New York v. Actavis: Making a Hard-Switch Procompetitive.” 8 Jan. 2015. View

- “The Concept of Brain Death and the Tragic Cases of Marlise Munoz and Jahi McMath.” 26 Jan. 2014. View

- “Antitrust Implications of Reverse Patent Settlements.” 13 Jul. 2013. View

- “Thoughts on Myriad.” 14 Jun. 2013. View

- “India Aggressively Expanding Access to Medicines.” 3 Jun. 2013. View

- “The High Price of Drugs – and Why Doctors Should Care.” 29 Apr. 2013.View

- “Beyond the Patents-Prizes Debate.” 21 Apr. 2013. View

- “Of Evergreening and Efficacy, Part III.” 16 Apr. 2013. View

- “Of Evergreening and Efficacy, Part II.” 15 Apr. 2013. View

- “Of Evergreening and Efficacy.” 2 Apr. 2013. View

"Transforming the Nature of Drug Safety." RegBlog: A Source of Regulatory News, Analysis, and Opinion in Affiliation with the Penn Program on Regulation. June 17, 2013. View

"Of Evergreening and Efficacy: The Glivec Patent Case." GESPAM. April 29, 2013. View

"Potential Elements of the WHO Global R&D Treaty: Tailoring Solutions for Disparate Contexts." Intellectual Property Watch. January 29, 2013. View

"Access to Medicines and Intellectual Property in Jordan." Intellectual Property Watch. July 23, 2012. View